awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39294879-1F8F9F7B-9BBF-415C-A5E3-315DC7BD1802
Q39294879-1F8F9F7B-9BBF-415C-A5E3-315DC7BD1802
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39294879-1F8F9F7B-9BBF-415C-A5E3-315DC7BD1802
Where Do the New Drugs Fit in for Relapsed/Refractory Hodgkin Lymphoma?
P2860
Q39294879-1F8F9F7B-9BBF-415C-A5E3-315DC7BD1802
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39294879-1F8F9F7B-9BBF-415C-A5E3-315DC7BD1802
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ff68b647a34a22ae5d1045ee873feb6bfd7686bc
P2860
PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study.